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Objectives: Diabetes mellitus (DM) is associated with a variety of sensory complications. 
Very little attention has been given to auditory neuropathic complications in DM. The aim of 
this study was to determine whether type 1 DM (T1DM) affects neural coding of the rapid 
temporal fluctuations of sounds, and how any deficits may impact on behavioral 
performance. 
Design: Participants were 30 young normal-hearing T1DM patients, and 30 age-, sex-, and 
audiogram-matched healthy controls. Measurements included: electrophysiological measures 
of auditory nerve and brainstem function using the click-evoked auditory brainstem response 
(ABR), and of brainstem neural temporal coding using the sustained frequency-following 
response (FFR); behavioral tests of temporal coding (interaural phase difference, IPD, 
discrimination and the frequency difference limen, FDL); tests of speech perception in noise; 
and self-report measures of auditory disability measures using the Speech, Spatial and 
Qualities (SSQ) hearing scale. 
Results: There were no significant differences between T1DM patients and controls in the 
ABR. However, the T1DM group showed significantly reduced FFRs to both temporal 
envelope and temporal fine structure. The T1DM group also showed significantly higher IPD 
and FDL thresholds, worse speech-in-noise performance, as well as lower overall SSQ scores 
than the control group. 
Conclusions: These findings suggest that T1DM is associated with degraded neural temporal 
coding in the brainstem in the absence of an elevation in audiometric threshold, and that the 
FFR may provide an early indicator of neural damage in T1DM, before any abnormalities can 
be identified using standard clinical tests. However, the relation between the neural deficits 
and the behavioral deficits is uncertain. 
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Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycaemia, with 1 
disturbances in the metabolism of carbohydrates, fat and protein resulting from defects in 2 
insulin secretion, insulin action or both. Several pathogenic processes may result in the 3 
development of DM. These include autoimmune destruction of beta cells in the pancreas, 4 
resulting in insulin deficiency, as seen in type 1 DM (T1DM), as well as other factors that 5 
result in resistance to the action of insulin on the target tissues, which is the case in the 6 
majority of in type 2 DM (T2DM) patients (Alberti & Zimmet 1998).  7 
The investigation of the relation between DM and disorders of the auditory and 8 
vestibular systems has been going on for over a century (Jordão 1857, cited in McQueen et al. 9 
1999), however, the association remains controversial and conflicting results are reported in 10 
the literature. The results of some animal and human studies point to changes in anatomical 11 
structures such as increased thickness of inner ear and basilar membrane (BM) vessels (Costa 12 
1967; Smith et al. 1995; Fukushima et al. 2006; Kariya et al. 2010), loss of outer hair cells 13 
(Nakae & Tachibana 1986; Triana et al. 1991; Raynor et al. 1995; Fukushima et al. 2006), 14 
and demyelination of the auditory nerve (AN) (Makishima & Tanaka 1971). Diabetic 15 
abnormalities have also been demonstrated in the central auditory pathways and brain, 16 
however, the pathogenesis is still unclear (Reske-Nielsen et al. 1965; Luse et al. 1970; 17 
Makishima & Tanaka 1971; Jakobsen et al. 1987; Dejgaard et al. 1991). 18 
Studies of the hearing health of DM patients have tended to focus on pure tone 19 
audiometry (PTA). Meta-analyses have found that the presence of DM roughly doubles the 20 
odds of developing an audiometric hearing loss, with a greater effect at high frequencies 21 
(Horikawa et al. 2013; Akinpelu et al. 2014a). However, audiometric hearing loss is not an 22 
inevitable consequence of DM. Some studies report no hearing loss compared to sex- and 23 
age-matched controls (Friedman et al. 1975; Dalton et al. 1998).  24 
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Although neuropathy is one of the more common complications in DM, affecting up 25 
to 50% of patients (Boulton et al. 2004), little attention has been given to neuropathic 26 
complications in DM involving the AN and central auditory pathways. These deficits, even in 27 
the absence of an elevation in audiometric threshold, may result in listening difficulties 28 
(Moore 2008). Studies using the auditory brainstem response (ABR) have found some 29 
differences between the ABR waveforms of DM patients and those of sex- and age-matched 30 
controls (Parving et al. 1990; Bayazit et al. 2000; Lisowska et al. 2001; Frisina et al. 2006; 31 
Konrad-Martin et al. 2010). The amplitude of wave I of the ABR, which reflects auditory 32 
nerve function, is often little affected in normal-hearing DM patients compared to controls 33 
(Al-Azzawi et al. 2004; Spankovich et al. 2017). Although there are reports of increased 34 
wave I latency in DM patients, even in the presence of normal audiometric hearing (Al-35 
Azzawi et al. 2004; Durmus et al. 2004; Acar et al. 2012), a recent meta-analysis found no 36 
significant effect (Akinpelu et al. 2014a). The evidence for central auditory neural 37 
dysfunction is stronger. Increases in central wave latencies and increased I-V, III-V and I-III 38 
inter-peak intervals (Martini et al. 1986; Parving et al. 1990; Durmus et al. 2004; Vaughan et 39 
al. 2007; Konrad-Martin et al. 2010; Rance et al. 2014; Rance et al. 2016), as well as reduced 40 
amplitudes for waves III and V (Rance et al. 2014), have been reported. These results are 41 
considered a sign of delayed conduction of neural response and/or loss of neural synchrony and 42 
suggest that DM is associated with an increase in neural transmission time, possibly as a 43 
result of demyelination. 44 
Very few studies have investigated the behavioral consequences of neuropathic 45 
complications in DM patients. These studies have identified trends of sub-clinical temporal 46 
processing difficulties, leading to perceptual difficulties in challenging acoustic environments 47 
(Frisina et al. 2006; Rance et al. 2014; Rance et al. 2016; Silva et al. 2016).  Some studies 48 
have found that speech discrimination scores in quiet and in noise were lower in DM patients 49 
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with normal PTA thresholds compared to controls, with a greater difference in the speech-in-50 
noise conditions (Kakarlapudi et al. 2003; Rance et al. 2014; Silva et al. 2016). 51 
A review of the literature shows little agreement about the impact of DM on auditory 52 
function, let alone specifically on the involvement of the AN and central neural pathways and 53 
reveals the need for further research, using more sensitive assessment methods with the 54 
ability to detect significant sub-clinical changes in the auditory system. The overall aim of the 55 
present study was to determine whether T1DM affects processing in the AN and brainstem, 56 
in particular coding of the temporal aspects of sounds, and how any deficits may impact on 57 
behavioral performance.  58 
The main limitation shared by most of the published studies that have investigated the 59 
relation between DM and hearing deficits is the choice of participant samples, exemplified by 60 
lack or inadequacy of matched control groups, mixing of type 1 and type 2 DM patients, and 61 
use of elderly DM participants. Unmeasured or imprecisely assessed potential confounding 62 
factors, such as participants’ age, type of DM, presence or absence of DM complications, and 63 
co-morbidity, may have caused a multitude of conflicting outcomes and made it difficult to 64 
determine the possible associations between these variables, and consequently the 65 
physiological basis of the auditory dysfunction in DM. In an attempt to avoid such 66 
confounds, strict recruitment criteria were used in the present study to only include young 67 
(aged 18-35 years) T1DM patients with binaurally hearing thresholds of 20 dB HL or better 68 
for frequencies ranging from 500 to 4000 Hz. The study also used tight pair matching to 69 
controls with respect to age, sex, and audiometric thresholds. Moreover, DM-related factors 70 
such as DM duration and the presence of clinically diagnosed neuropathy and retinopathy were 71 
obtained with a secondary aim of investigating their effects on the results of the experimental 72 
measures used in the study. It was hypothesized that patients with diabetic neuropathy or 73 
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retinopathy are more likely to present with neuropathic complications involving the AN and 74 
central auditory pathways. 75 
In addition to the ABR, the test battery included the electrophysiological frequency-76 
following response (FFR). The FFR reflects sustained neural activity, phase locked to the 77 
cycles of the stimulus waveform. Two types of information are represented: the envelope, 78 
which corresponds to slow variations in overall amplitude over time, and the temporal fine 79 
structure (TFS) which corresponds to the rapid individual variations in sound pressure 80 
(Moushegian et al. 1973; Moore 2008). Accurate encoding of both the envelope and TFS of a 81 
stimulus is believed to be important for understanding speech, especially in noisy 82 
environments (Sachs et al. 1983; Rosen 1992; Lorenzi et al. 2007). The FFR is thought to 83 
originate mainly from brainstem generators, although there may also be AN and cortical 84 
contributions (Bidelman et al. 2015; Coffey et al. 2016). To the authors’ knowledge, no study 85 
has explored DM-related auditory deficits with the use of the FFR, although the FFR has 86 
been shown to be sensitive to pathological changes in the AN in other patient populations 87 
(McAnally & Stein 1996; Basu et al. 2009; Russo et al. 2009; Jafari et al. 2015).  88 
The test battery also included speech-in-noise tests, and behavioral tests assumed to 89 
be dependent on temporal coding: interaural phase difference (IPD) discrimination, and the 90 
frequency difference limen (FDL). The inter-aural timing difference (ITD), which for 91 
periodic and ongoing tones such as pure tones translates to IPD, is the difference in arrival 92 
time of a sound between the two ears. ITD and IPD are the most important cues to sound 93 
localization for most natural sounds in the environment in which low frequency components 94 
are present (Wightman & Kistler 1992). The FDL is another commonly used behavioral 95 
measure of temporal coding. There is still debate as to whether pure-tone frequency 96 
discrimination depends on temporal or place coding cues at high frequencies, although 97 
temporal cues are probably used to perform the task at the frequency of 590 Hz used here 98 
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(Sek & Moore 1995). (For a review of pitch perception theories, see Moore 2013 and Plack 99 
2018.) 100 
Although self-report auditory disability measures are commonly used in hearing 101 
research, few studies have assessed DM individuals’ subjective experience of hearing 102 
disability to determine whether the postulated effects of DM on auditory function manifest in 103 
realistic listening situations. Using the Abbreviated Profile of Hearing Aid Benefit 104 
hearing/communication disability questionnaire, Rance et al. (2016) found that 19 school-age 105 
children with T1DM reported significantly greater difficulties, particularly in noisy or 106 
reverberant environments such as classrooms and playgrounds, compared to age- and sex-107 
matched controls. In the present study, self-reported ability to hear in different everyday 108 
situations was measured using the Speech, Spatial and Qualities (SSQ) hearing scale. 109 
The primary research questions were: 110 
1. Do T1DM patients show evidence of cochlear neuropathy or central neural 111 
dysfunction?   112 
2. Is T1DM associated with poorer performance on behavioral tasks in the absence of 113 
an elevation in audiometric threshold? 114 
3. Is T1DM associated with self-report of auditory disability in the absence of an 115 
elevation in audiometric threshold? 116 
METHODS 117 
Participants 118 
The sample size was calculated based on a related pilot study (unpublished MSc 119 
dissertation) with an effect size, d, of 0.49. This power calculation (G* power calculator, 120 
v3.1) suggested a minimum sample size of 27 participants per group to provide a statistical 121 
power value of 0.8 for a one-tailed prediction and an alpha level of 0.05 to detect a difference 122 
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between the two groups, based on a paired samples t-test. In order to allow for drop-out or 123 
larger than expected measurement variability, 30 participants per group were recruited. It is 124 
worth noting that the sample size adopted in this study is larger than in the two similar studies 125 
which were published after the start of the current study by Rance et al. (2014; 2016) (n = 10 126 
and 19 per group respectively). As discussed above, these studies were able to detect 127 
significant group differences between T1DM and the matched controls in all of the measures 128 
used, including ABR, speech-in-noise, and self-report measures. Thus, the sample size used 129 
in this study was expected to be sufficient to detect differences in these same measures. Sixty 130 
young audiometrically normal adults participated (binaural hearing thresholds for all 131 
participants were < 20 dB HL for frequencies ranging from 500 to 4000 Hz). Thirty were 132 
T1DM participants (mean age, 26.8 years; range, 19-35 years; 22 females) (see Table, 133 
Supplemental Digital Content 1, for the details of the 30 T1DM participants). The T1DM 134 
participants were pair-matched to 30 controls in terms of age, sex and PTA threshold. For 135 
T1DM participants, T1DM diagnosis was confirmed through their consultant physicians or 136 
general practitioner, whereas each control participant reported that he/she was DM free; 137 
however, no measurement of blood glucose was taken to confirm the absence of DM in the 138 
control group. All participants had English as their first language.  139 
A decision was made at the beginning of the study to test the right ear of all 140 
participants, for monaural tests, unless the left ear average hearing threshold was at least 15 141 
dB less than the right ear. The right ear was tested monaurally for all 60 participants. Criteria 142 
for matching T1DM and control participants were a difference in age of 11 months or less, 143 
and a difference in PTA thresholds of the test ear of 5 dB or less for each frequency at 0.5, 1, 144 
2, and 4 kHz (see Table, Supplemental Digital Content 2, for the details of the 30 matched 145 
pairs). However, it should be noted that although no efforts were made to match PTA 146 
thresholds at higher frequencies (6 and 8 kHz), no significant difference was found between 147 
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the two groups in PTA thresholds of the test ears at 6 nor 8 kHz (N= 30, z = -1.20, p = 0.16 148 
and t (29) = 0.97, p = 0.44, respectively) (see Fig. 1). The procedures were approved by an 149 
NHS research ethics committee (reference number 12/NW/0319).  150 
 ***Insert Fig. 1*** 151 
Electrophysiological Measures 152 
General Procedure 153 
All electrophysiological recordings were made in a single 2-h session using TDT 154 
BioSig software. All stimuli were generated using MATLAB (MathWorks, 2010) and 155 
presented to the right ear via a TDT RP2.1 Enhanced Real Time Processor and HB7 156 
Headphone Driver with the participant’s left ear plugged using a foam plug.  Recordings 157 
were made with the participant reclined on a chair and free to close their eyes and relax or fall 158 
asleep. Many fell asleep throughout the duration of the testing period; however, participants’ 159 
wakefulness was not recorded. 160 
ABR Procedure and Analysis 161 
Participants were presented with 100-μs alternating polarity clicks at a level of 100 dB pe 162 
SPL and at a rate of 11.1 per second using ER-3A insert headphones. Online filtering was 163 
applied with a high-pass filter at 100 Hz and a low-pass filter at 3000 Hz. A vertical electrode 164 
montage was used, with an active electrode at the high forehead hairline (Fz), a reference 165 
electrode at the right mastoid, and a ground at low forehead (Fpz). Impedances were 166 
maintained below 5 k Ω. ABR waveforms were averaged across 8000 presentations of each 167 
polarity. 168 
Absolute latencies and amplitudes for waves I, III and V of the ABR for each 169 
participant were computed on-line using the computer cursor. Recordings were exported to 170 
text files and ABR waveforms were plotted within a 0-10 ms time window by a MATLAB 171 
script. For each participant, the peaks of waves I, III and V were chosen by the first author 172 
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and were then checked a second time by an additional expert who was blind to the condition 173 
of each participant, thus providing reliability. There was no inconsistency between 174 
researchers during this selection process. Component amplitudes for waves I, III and V were 175 
defined as the electric potential differences between peak and following trough. Absolute 176 
latencies were then used to calculate I-III, III-V and I-V inter-peak intervals. Peak-to-trough 177 
amplitudes for waves I, III and V were used to calculate I-III, III-V and I-V ratios. 178 
FFR Procedure and Analysis 179 
FFR recordings took place immediately after the ABR recordings. Five amplitude-180 
modulated (AM) stimuli were presented, which allowed the TFS and temporal envelope 181 
phase locking components to be measured simultaneously. Each stimulus consisted of three 182 
equal-amplitude pure-tone components. The central component had a frequency of 590 Hz 183 
and the two side-bands were spaced below and above this component in frequency, with 184 
spacings of 95 to 135 Hz in 10 Hz increments. Each spacing also corresponds to the 185 
amplitude modulation rate (fm) of the three-tone complex. The frequency components (in Hz) 186 
of the five stimuli were: 495-590-685; 485-590-695; 475-590-705; 465-590-715 and 455-187 
590-725. Each component started in sine phase. Each stimulus was 200-ms in duration, 188 
including 10-ms raised-cosine onset and offset ramps. Each presentation window contained 189 
two stimuli separated by 125-ms silence. The onset polarity of the second stimulus in the pair 190 
was inverted with respect to the onset polarity of the first stimulus (Goblick & Pfeiffer, 191 
1969). The overall stimulus level was 80 dB SPL. Presentations consisting of the two stimuli 192 
were repeated at a rate of 1.5/sec. For each condition, FFR waveforms were averaged across 193 
1500 presentations (three grand averages of 500 sweeps) of each polarity.  194 
Stimuli were delivered using Etymotic ER30 transducers, with 6 m tubing connecting 195 
the transducers to the ear tips. This enabled the transducers to be positioned outside the 196 
experimental booth, therefore avoiding stimulus artefacts. Stimuli were presented in a 197 
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random order to counteract any effects of restlessness from participants toward the end of 198 
testing. A vertical montage was used to record the FFR with an active electrode at Fz, a 199 
reference electrode at the C7, and a ground at Fpz (Krishnan & Plack, 2011). Impedances 200 
were maintained below 5 kΩ. Online filtering was applied, with high-pass filtering at 30 Hz, 201 
low-pass filtering at 3000 Hz, and a notch filter at 50 Hz to remove mains electrical noise.  202 
Recordings were exported to text files, read and analyzed offline by MATLAB 203 
scripts. Recording average responses to a direct polarity and to an inverted polarity version of 204 
each stimulus allowed the assessment of the neural representation of the temporal envelope 205 
and TFS separately. By adding the average FFRs to the direct stimulus polarity and to the 206 
inverted polarity (FFRadd), phase locking to the envelope is enhanced and phase locking to 207 
TFS is suppressed. By subtracting the FFR to the inverted stimulus polarity from the FFR to 208 
the direct stimulus polarity (FFRsub), the contribution of phase locking to the temporal 209 
envelope component is reduced and the contribution of phase locking to the TFS is enhanced 210 
(Goblick & Pfeiffer, 1969). For the FFRadd, the discrete Fourier transform (DFT) at the 211 
modulation rate was calculated from the mean added responses for each stimulus condition. 212 
For the FFRsub, the DFT at the component frequencies (lower side band, carrier frequency 213 
and upper side band) was calculated from the mean subtraction waveform for each stimulus 214 
condition.  215 
To estimate the strength of the target frequency representation in the FFR relative to 216 
background noise activity, signal-to-noise ratios (SNRs) were calculated as the ratios between 217 
the DFT amplitude in the FFR centered at the target frequency and the average DFT 218 
amplitude across bands 5-33 Hz below the target frequency and 5-33 Hz above the target 219 
frequency. The SNRs were averaged across frequency spacing conditions and then converted 220 
to dB. For subtracted polarities, the SNR value was calculated for responses to the upper and 221 
lower side-band frequencies for each condition separately. However, in order to estimate an 222 
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overall value for the strength of phase locking to the TFS in each condition, the average of 223 
SNRs at the carrier frequency and at the two side bands for subtracted polarities (Mean 224 
FFRsub) was taken.  225 
To estimate the sustained latency of the envelope and TFS FFR, a MATLAB script 226 
was run to obtain a measure of group delay. The programme starts by selecting a group delay 227 
value, then calculates what phase each frequency component should have based on the group 228 
delay value selected (predicted phase). These predicted phase values are then compared 229 
against the actual phase values, after unwrapping to find the best fit. The sum of squared 230 
deviations of predicted versus observed phase values is then calculated across frequency 231 
components. To obtain the group delay final estimate, the procedure is repeated, by varying 232 
the selected group delay value, until the group delay value that minimizes the sum of squares 233 
is found. For a frequency component to be included in the group delay final calculation, a 234 
statistical criterion based on the SNR was used to determine the presence or absence of a 235 
response to the stimulus. An FFR response was accepted as present if the magnitude of the 236 
DFT at the target frequency was greater than the mean magnitude at noise frequencies 237 
surrounding it by 3 SDs of the magnitude across the noise frequencies. Noise frequencies 238 
were selected at a resolution of 2 Hz, from 5 to 33 Hz above and below the signal frequency. 239 
A group delay calculation was only included if at least three data points passed the criterion.  240 
Behavioral Measures 241 
General Procedure 242 
All testing occurred in a double-walled sound attenuating booth. Signals were created 243 
in MATLAB, and presented to the participant via Sennheiser HD 650 circum-aural 244 
headphones. 245 
IPD and FDL Tests  246 
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Using a procedure based on that described by Hopkins and Moore (2010), 247 
participants’ sensitivity to IPDs was measured for 590-Hz pure tones.  This frequency was 248 
chosen as a common frequency test for the behavioral measurements for temporal coding of 249 
sounds in the current study and FFR measurements in study one. A two-interval, two-250 
alternative forced-choice task was used. Each interval comprised four 200-ms tones, 251 
including 10-ms raised-cosine onset and offset ramps, that were synchronous across ears. The 252 
tones were separated by 20-ms of silence within each interval and 500-ms of silence between 253 
the two intervals. In one interval the four tones all had a zero IPD (AAAA). However, in the 254 
other interval, the second and fourth tones had a nonzero IPD (ABAB). The two intervals 255 
were randomly ordered. This form of presentation is thought to provide a clear cue for naïve 256 
listeners, and to reduce the training time required to achieve asymptotic performance (King et 257 
al. 2013). Tones were presented binaurally at 80 dB SPL.  258 
Participants were instructed to pick the alternating interval by pressing a key (1 or 2) 259 
on a computer keyboard and were advised to focus on lateral position alternation, but that 260 
they were free to use any perceptual cue to perform the task. The response was followed by 261 
visual feedback to indicate whether the response was right or wrong. The target IPD (δ°) was 262 
initially set to 180° and could not exceed this value. A geometric adaptive two-down, one-up 263 
procedure was used. Each block of trials consisted of 16 reversals (changes in track 264 
direction). The step size was set to a factor of 2 until four reversals occurred and a factor of 265 
1.141 for the following 12 reversals. For each block, the IPD discrimination threshold was 266 
taken as the geometric mean of δ at the last 12 reversals. Each participant completed four 267 
blocks, and the geometric mean of the last three IPD discrimination thresholds was taken as 268 
the final estimate.  269 
FDLs were measured for the same 590-Hz pure tone used for the IPD measure. Tones 270 
were presented to the right ear at 80 dB SPL. An AAAA vs. ABAB two-alternative task was 271 
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used (as for IPD), with the B tones having a higher frequency than the standard 590 Hz A 272 
tones. The two intervals were randomly ordered. The procedure for estimating threshold was 273 
the same as for the IPD task, except that the percentage frequency difference between the A 274 
and B tones was varied adaptively. 275 
Speech in Spatial Noise Test  276 
Target sentences were taken from the adaptive sentence list (ASL) corpus (MacLeod 277 
& Summerfield, 1990) and the talker was a male speaker of British English. ICRA06, which 278 
represents a two-speaker background noise with two equally loud speakers of different 279 
gender (1 female 3bSMN + 1 male 3bSMN) speaking at normal vocal effort (Dreschler et al. 280 
2001), was used as the competing noise masker. Target speech was presented to the 281 
participants at a constant rms level of 65 dB SPL with a sampling rate of 22,050 Hz. The 282 
level of the competing talker was varied to give the appropriate SNR, except when the SNR 283 
was less than −16 dB. Below this SNR, the level of the competing talker was not increased 284 
further, but instead the level of the target speech was reduced, to prevent the combined signal 285 
becoming uncomfortably loud. In practice, this was not necessary for any of the participants. 286 
Two conditions were tested: one in which head-related impulse responses (HRIRs) 287 
corresponding to 0, 60 and 300 degrees azimuth were used for the target and two masker 288 
sentences, respectively (separated condition), and one in which the target and background 289 
speech were presented simultaneously from the front at 0º azimuth (co-located condition). 290 
HRIRs were taken from the freely available CIPIC database (Algazi et al. 2001).  291 
Participants were asked to repeat sentences presented in a competing talker 292 
background. The background began 500 ms before the target sentence, and continued after 293 
the target sentence had finished for about 700 ms (the exact value depended on the length of 294 
the target sentence). The testing session began with a short ‘warm up’ period, in which two 295 
lists (which were short versions with only half the number of sentences as the full ASL lists) 296 
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were presented in the separated and co-located condition respectively. The first sentence in 297 
each list was initially presented at 12 dB SNR. After this, two consecutively presented ASL 298 
sentence lists, each made up of 30 sentences, were used for each condition. The order of 299 
presentation of conditions was counterbalanced across pairs. Unlike the first two lists, the 300 
first sentence in each of the full lists was initially presented at 10 dB SNR. The SNR of the 301 
target and competing talker was varied adaptively. If a participant identified two or more 302 
keywords correctly in a sentence, the next sentence was presented with a SNR that was k dB 303 
lower, and if the participant identified fewer than two keywords correctly, the next sentence 304 
was presented with a SNR that was k dB higher. k was equal to 4 dB for the first two turn 305 
points, then equal to 2 dB for the subsequent turn points. The adaptive track continued until 306 
the 30 sentences were presented. For each sentence list, the total number of keywords 307 
presented at each SNR was recorded, as well as the number of keywords that were identified 308 
correctly for each SNR.  309 
For each SNR, the total keywords presented and keywords correct were summed for 310 
the two sentences lists that were presented for each condition (Hopkins & Moore 2009). 311 
These values were used to perform a probit analysis (Finney, 1971), from which the SNR 312 
required for 50% correct identification was estimated for each participant and each condition. 313 
For each condition, the mean of the estimated two SNR values, required for 50% correct 314 
identification for the two used sentence lists, was taken as the final estimate (the SNRs for the 315 
two short lists were not included in the final estimate). Spatial release from masking (SRM; 316 
Plomp & Mimpen 1981; Hawley et al. 1999) was measured by calculating the difference 317 
between the SNR for 50% correct in the co-located condition and the SNR for 50% correct in 318 
the separated condition. 319 
Self-Report of Auditory Disability Measures 320 
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Participants’ self-report ability to hear in different everyday situations was measured 321 
on their first session, before assessing their hearing ability using PTA. This was done in order 322 
to not bias the self-report results. The original 49-item version of the SSQ (Gatehouse & 323 
Noble, 2004) was administrated for the current study. The 49 items were related to three 324 
subscales, with 14 items assessing an individual’s ability to detect and understand speech in a 325 
variety of competing contexts (Speech subscale), 17 items assessing spatial listening abilities 326 
(Spatial subscale), and 18 items assessing qualities of hearing including ease of listening, 327 
naturalness and clarity of sounds (Qualities subscale).  328 
Most of the participants (n = 44) completed the SSQ questionnaire in an interview 329 
format in a quiet room. The researcher read the questions aloud, and participants were asked 330 
to respond to each item, by marking a number, rating themselves with a score on a scale 331 
ranging from 0 (not able at all, complete absence of a quality or total need for effort) to 10 332 
(perfectly able to, complete presence of a quality or complete absence of the need for effort). 333 
Singh and Pichora-Fuller (2010) found minimal differences in mean SSQ scores when the 334 
questionnaire was given in an interview format or completed at home and returned by mail. 335 
Therefore, participants were given the option to complete by either method. Only 16 336 
participants (nine controls and seven T1DM) chose to complete the questionnaire on their 337 
own. Those received the questionnaire form together with the participant information sheet 338 
and returned it on their first session.  339 
Statistical Analyses 340 
All statistical analyses were carried out with SPSS (IBM statistics SPSS version 22). 341 
If the difference between the paired values of a measure was normally distributed, paired 342 
samples t-tests were run. However, when the difference was not normal, and could not be 343 
normalized using transformation algorithms, a nonparametric Wilcoxon signed-ranks test was 344 
used.  Correlation coefficients, Pearson’s (r) or Spearman’s (rs) for nonnormally distributed 345 
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variables, were calculated to assess the relations between measures. Bonferroni correction 346 
was used to control for multiple comparisons within each research question. 347 
RESULTS 348 
Electrophysiology   349 
Figure 2 shows the grand average ABR waveforms plotted for the control and the 350 
T1DM groups.  Figure 3 shows wave I, III, and V peak-to-trough amplitudes (upper panel) and 351 
absolute latencies (lower panel) for the two groups. The difference between the two groups was 352 
not significant for any of the ABR amplitude or latency measures (see Table, Supplemental 353 
Digital Content 3, which shows the statistics for all variables used in the analyses on the ABR 354 
data). 355 
***Insert Fig. 2*** 
***Insert Fig. 3*** 
Figure 4 shows the average added (A) and subtracted (B) waveforms of the FFR for 356 
one of the five stimuli (475-590-705 Hz). Figure 4 also shows the average added (C) and 357 
subtracted (D) spectra. Spectral peaks can clearly be seen corresponding to the modulation 358 
frequency in the addition spectra, and to the component pure tone frequencies in the 359 
subtraction spectra. The FFRs for the control group are larger than those for the T1DM 360 
group. 361 
***Insert Fig. 4*** 
Figure 5 shows FFR SNRs and group delays for the different measures. Only a 362 
proportion of the matched pairs had values for each group delay measure that passed the SNR 363 
criteria. The number of T1DM participants with available group delay values was 18 for 364 
FFRadd and 29 for FFRsub. The number of control participants with available group delay 365 
values was 27 for FFRadd and 30 for mean FFRsub. Thus, the number of group delay values 366 
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for FFRadd was substantially smaller for the T1DM group than for the control group. The 367 
number of matched pairs available for the analysis was 17 for FFRadd and 29 for mean 368 
FFRsub. 369 
After applying a Bonferroni correction (α = 0.0063), the difference between the two 370 
groups was significant for all the SNRs values for FFRadd, FFRsub lower side band, FFRsub 371 
upper side band and mean FFRsub (see Table 1). However, none of the group delay values 372 
was significantly different between the two groups (see Table, Supplemental Digital Content 373 
4, which shows the statistics for all variables used in the analyses on the FFR group delay 374 
data).  375 
***Insert Fig. 5*** 
***Insert Table 1*** 
Relations Between Amplitude or Latency Measures of ABR and FFR  376 
In Bonferroni corrected correlations (α = 0.0063), a significant correlation was 377 
observed between group delay for FFRadd and ABR wave V absolute latency in the T1DM 378 
group (n= 18, rs = 0.63, p = 0.005). However, this correlation was not significant in the 379 
control group. No significant correlation was found between SNRs for FFRadd or mean 380 
FFRsub and wave V peak-to-trough amplitudes for the ABR, for either the control or T1DM 381 
groups. 382 
Behavioral Measures 383 
Figure 6 shows the log-transformed IPD thresholds and log-transformed FDLs for the 384 
control and the T1DM groups. In a Bonferroni corrected paired t test (α = 0.01), log-transformed 385 
IPD thresholds and log-transformed FDLs were both significantly higher for the T1DM group 386 
than for the controls (see Table 2). 387 
 ***Insert Fig. 6***  
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Figure 7 shows the SNR for 50% correct for the control and T1DM groups for the 388 
separated and co-located speech conditions. There was a significant difference between the 389 
two groups after Bonferroni correction in both conditions (see Table 2). However, there was 390 
no significant group difference in SRM. 391 
***Insert Table 2*** 
***Insert Fig. 7*** 
Relations Between the Behavioral Measures 392 
Log-transformed IPD thresholds were strongly correlated with log-transformed FDLs 393 
in the control and T1DM groups (r = 0.70, p < 0.001; and r = 0.60, p < 0.001, respectively). 394 
A strong correlation was also observed between the SNR for 50% correct in the separated and 395 
in the co-located condition in the control and T1DM groups (r = 0.74, p < 0.001; and r = 396 
0.73, p < 0.001, respectively). The correlation between log-transformed FDLs and SNRs for 397 
50% correct in the separated condition for the T1DM group did not remain significant after 398 
the correction (r = 0.47, p = 0.02; α = 0.0063). There were no other significant correlations 399 
between FDLs or IPD thresholds and speech-in-noise measures. 400 
Self-Report of Auditory Disability Measures 401 
Figure 8 shows the SSQ subscale scores, and the overall SSQ scores, for the control and 402 
T1DM groups. An ANOVA revealed significant main effects of group and SSQ subscale (F 403 
(1, 58) = 24.04, p < 0.001; F (2, 12) = 26.74, p < 0.001, respectively), and there was also a 404 
significant interaction between group and SSQ subscale (F (2, 12) = 4.07, p < 0.02). In 405 
Bonferroni corrected paired t-tests (α = 0.013) the T1DM group showed significantly lower 406 
scores than the control group on each of the SSQ subscales. The T1DM group had significantly 407 
lower overall SSQ scores than the control group (Table 3).  408 
***Insert Fig. 8*** 
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***Insert Table 3*** 
Relations Between the Experimental Measures and the Effects of DM-Related Factors 409 
The primary focus of this study was to determine whether T1DM affects neural 410 
coding of the rapid temporal fluctuations of sounds, and how any deficits may impact on 411 
behavioral performance, and not on the relations between experimental measures. Since there 412 
was a significant difference between the two groups in most of the measures, these significant 413 
measures also correlate across the whole cohort. For the present analysis, groups were 414 
analyzed separately when investigating the relations between the experimental measures and 415 
only statistically significant correlations following Bonferroni correction are reported and 416 
discussed.  417 
Relations Between Experimental Measures 418 
Neither ABR wave I nor wave V peak-to-trough amplitudes nor absolute latencies 419 
correlated significantly with any of the behavioral measures, for either the control or T1DM 420 
groups (see Table, Supplemental Digital Content 5). Nor was there a significant relation 421 
between FFRadd, mean FFRsub SNRs nor FFR group delay values and any of the behavioral 422 
measures, for either the control or the T1DM groups (see Table, Supplemental Digital 423 
Content 5). One weak correlation was observed between FFRadd SNRs and log-transformed 424 
IPD thresholds in the T1DM group. However, this correlation did not remain significant after 425 
the correction (α = 0.0031). In Bonferroni corrected correlations, for the T1DM group there was 426 
a significant correlation between wave I latency and log-transformed FDLs (r = 0.85, p < 0.001), 427 
but no significant correlation between wave I latency and log-transformed IPD threshold.  428 
No correlation remained significant, following a Bonferroni correction (α =0.0063), 429 
between overall SSQ scores and ABR or FFR amplitude and latency measures, for either the 430 
control group or for the T1DM group. However, there was a strong correlation between overall 431 
SSQ scores and SNRs in the separated condition, for the T1DM group (r = -0.48, p = 0.008).  432 
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The Effects of DM-Related Factors 433 
After Bonferroni correction (α = 0.0063), FFRadd and mean FFRsub SNRs correlated 434 
significantly with DM duration (rs = -0.7, p < 0.001, rs = -0.6, p = 0.005, respectively, Fig. 435 
9). None of the other measures correlated significantly with DM duration. Independent-436 
samples t-tests showed no significant difference between T1DM participants with clinically 437 
diagnosed neuropathy or retinopathy and those without, for any of the experimental 438 
measures.  439 
***Insert Fig. 9*** 
DISCUSSION 440 
Do T1DM Patients Show Evidence of Cochlear Neuropathy or Central Neural 441 
Dysfunction?   442 
ABR  443 
In the current study, the amplitudes and absolute latencies for ABR wave I were 444 
similar across the two groups, showing no evidence of cochlear neuropathy. These results are 445 
in keeping with those of Rance et al. (2014), who found that peripheral auditory function in 446 
listeners with T1DM was normal, with distortion-product otoacoustic emissions (DPOAEs) 447 
present in each ear, indicating normal cochlear function, and that absolute latencies and 448 
amplitudes for wave I of the click-evoked ABR were equivalent to the age- and sex-matched 449 
controls. It is known that high frequency hearing loss as a result of damage to the basal 450 
segments of the cochlea can cause a delay in wave I with no effect on wave V latency, 451 
making the wave I–V interval shorter (Coats & Martin, 1977). However, in the present study, 452 
PTA thresholds at 6 and 8 kHz were similar across the two groups.  453 
No significant differences were found between the control and T1DM groups in peak-to-454 
trough amplitudes or absolute latencies of waves III and V; nor were any significant 455 
differences found between the two groups in peak-to-trough amplitude ratios or inter-peak 456 
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intervals for I-III, III-V and I-V. Thus, the present ABR data provide no clear evidence of 457 
reduced conduction efficiency, which may result from demyelination, nor of neural 458 
dyssynchrony, another possible consequence of demyelination or axonopathy, in T1DM 459 
patients in the absence of an elevation in audiometric threshold. The results of this study are 460 
in contradiction with those of studies which have found some differences between the ABR 461 
waveforms of DM patients and those controls (Bayazit et al. 2000; Frisina et al. 2006; 462 
Lisowska et al. 2001; Parving et al. 1990; Rance et al. 2014). A possible explanation for the 463 
discrepancy between the present results and previous findings is that the T1DM and healthy 464 
controls in the present study were closely PTA-matched, whereas DM PTA thresholds in 465 
previous studies were always elevated when compared with those of the controls, even in 466 
studies where DM average hearing levels were within normal or near-normal ranges (Rance 467 
et al. 2014; Rance et al. 2016). It is also possible that if a higher stimulus presentation rate 468 
had been used in the current study, ABR waveforms would have been more strongly affected 469 
by T1DM, as reported by Rance et al. (2014). They found the mean maximum rate with a 470 
recordable ABR for the T1DM group to be significantly lower than for the control group and 471 
concluded that the abnormal ABRs to high rate stimuli suggest that the neural systems of 472 
T1DM patients are more easily stressed compared to controls, consistent with the results in 473 
other neuropathologies such as multiple sclerosis (Fowler & Noffsinger, 1983). 474 
FFR 475 
The FFR SNRs for added polarities (envelope) as well as for the subtracted polarities 476 
(TFS) were significantly and substantially lower in the T1DM group compared to the age-, 477 
sex- and PTA-matched healthy controls. The reduced SNRs in T1DM patients suggest that 478 
the capability to phase lock to stimuli may be impaired as a result of neuropathy of the 479 
auditory pathway up to and including the rostral brainstem.  480 
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Similar to ABR latency results, the FFR group delay data provide little evidence that 481 
T1DM affects neural conduction time: no significant differences in group delay for responses 482 
to FFRadd and FFRsub were found between the T1DM and control groups, although there 483 
was a trend for prolonged group delay for FFRadd and FFRsub in the T1DM group. These 484 
results suggest either that ABR and FFR latencies are not sensitive to timing changes in the 485 
brainstem associated with T1DM or that these changes are slight in young normal-hearing 486 
T1DM patients.  487 
Relations Between ABR and FFR Amplitude and Latency Measures  488 
It has been claimed that the FFR has similar neural generators to wave V of the ABR, 489 
i.e., the inferior colliculus (Daly et al. 1976; Smith et al. 1975; Stillman et al. 1976). 490 
However, the evidence is inconclusive (Batra et al. 1986; Dolphin and Mountain, 1992; Gardi 491 
et al. 1979; Kuwada et al. 1986; Purcell et al. 2004). A poor correlation between ABR and 492 
FFR latencies was also reported when ABR and FFR were directly compared by Hoormann 493 
et al. (1992), suggesting multiple generators of the FFR, or that the FFR may have separate 494 
but also overlapping generators to the ABR (Batra et al. 1986; Bidelman et al. 2015; Davis & 495 
Britt 1984; Gardi et al. 1979; Stillman et al. 1978). Moreover, using 496 
magnetoencephalography, a recent study by Coffey et al. (2016) reported cortical 497 
contributions to the FFR in humans. 498 
In the present data, the FFRs to the envelope and the TFS were found to occur 499 
significantly later than wave V of the ABR. The only significant correlation was observed 500 
between group delay for the FFR to the envelope and ABR wave V absolute latency in the 501 
T1DM group. No strong conclusions can be drawn, due to the small sample size (n = 18) and 502 
the fact that this correlation was not significant in the control group (n = 27). In addition, 503 
neither of the amplitudes for these components was found to correlate with the amplitude of 504 
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ABR wave V. A larger sample is required to reliably determine the relation between ABR 505 
and FFR latencies.  506 
The results of the current study support earlier findings suggesting separate neural 507 
generators for the FFR and wave V (Hoorman et al. 1992) and indicating a separate 508 
processing component within the auditory brainstem that is unique to more complex stimuli 509 
(Song et al. 2006). These results may explain why T1DM participants in this study 510 
demonstrated a normal wave V latency and amplitude in the presence of a disordered FFR. It 511 
could be that DM-associated damage to parts of the auditory brainstem responsible for 512 
generating all or part of the continuous FFR does not affect its ability to generate wave V of 513 
the ABR.  514 
The current study suggests that the FFR may be more sensitive to subtle auditory 515 
processing deficits in T1DM patients than the ABR, and thus can identify deficits that may be 516 
missed if only the conventional click-evoked ABR is performed. The AM complex tones 517 
used to elicit the FFR may better represent the complex acoustic signals of speech (Alcántara 518 
et al. 2012; Shannon et al. 1995) than a click stimulus that lacks frequency specificity and 519 
ecological validity. The use of a more complex stimulus to assess the auditory brainstem 520 
function in T1DM patients could reveal temporal processing deficits to which the click-521 
evoked ABR may not be sensitive. However, although these results suggest that the FFR 522 
could have clinical potential as a diagnostic test to identify AN and brainstem neural 523 
processing deficits in patients with T1DM, measurement of the FFR has not yet proven to be 524 
sufficiently fast or reliable to rival a measurement such as the ABR. Future studies are 525 
required to determine the neural generators and to establish normative latency values for the 526 
FFR, as well as to further understand the relation between ABR and FFR measures. 527 
Is T1DM Associated with Poorer Performance on Behavioral Tasks, in the Absence of 528 
an Elevation in Audiometric Threshold? 529 
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T1DM patients in this study showed evidence of deficits in IPD sensitivity and 530 
frequency discrimination. These findings suggest an association between T1DM and 531 
deterioration in temporal processing abilities in the presence of normal hearing detection 532 
levels, providing support for the conclusion of Rance et al. (2014) that temporal processing 533 
abilities deteriorate in normal-hearing T1DM patients, as evidenced by impaired perception 534 
of rapid amplitude modulation. 535 
The present data also provide evidence of significantly impaired speech-in-noise 536 
performance in T1DM patients in the absence of an elevation in PTA thresholds, in keeping 537 
with previous speech audiometry research on normal-hearing DM patients (Kakarlapudi et al. 538 
2003; Rance et al. 2014). As expected, in the current study, the T1DM group showed 539 
significantly higher (worse) SNRs than the healthy controls in separated and co-located 540 
conditions. However, mean SRM values for the two groups were equivalent: the difference 541 
between two groups in separated and co-located conditions was roughly equal. This finding 542 
does not support the hypothesis that T1DM patients would have lower SRM values than those 543 
of the healthy controls, due to a decline in temporal coding. The results are in contrast with 544 
those of Rance et al. (2016), who found speech reception thresholds for children with T1DM 545 
to be significantly higher than the sex- and age-matched controls in the separated condition, 546 
where binaural difference cues were available, whereas mean reception thresholds for the two 547 
groups were equivalent when no binaural cues were available (co-located condition). Again, a 548 
possible explanation for the discrepancy between the present results and the findings of 549 
Rance et al. (2016) is the elevated PTA thresholds of their DM patients compared to those of 550 
the controls, whereas in the present study, the DM and healthy controls were closely PTA-551 
matched. 552 
The current results provide no evidence of a specific “binaural disadvantage” for DM 553 
participants and suggest that speech perception difficulties in T1DM patients are more 554 
26                                                 
AlJasser et al 
 
 
general deficits, possibly a combination of deficits in general temporal processing and neural 555 
coding, including frequency selectivity and/or intensity coding, as well as DM-related 556 
nonsensory cognitive deficits, which could affect auditory processing ability, such as 557 
attention (Rovet & Alvarez, 1997; Ryan et al. 1993) and memory (Biessels et al. 1994).  558 
Is T1DM Associated with Self-Report of Auditory Disability in the Absence of an 559 
Elevation in Audiometric Threshold? 560 
Mean scores on the SSQ were generally quite high for both groups, with the control 561 
group scoring higher than 8.7 points and the T1DM group scoring higher than 7.6 points for 562 
the mean overall SSQ score and mean SSQ subscale scores. The mean scores of the control 563 
group on all three subscales fall within the normal range established by Banh et al. (2012) for 564 
the best scores that could reasonably be expected from healthy young adults who have 565 
audiometric thresholds within normal limits, i.e., thresholds that are considered clinically 566 
normal in most or all of the speech range, and are not likely to be candidates for hearing aids. 567 
For Banh et al. (2012), in normal-hearing young adults, the mean overall SSQ and the SSQ 568 
subscale scores were 8.8, 8.5, 8.6, and 9.4 points respectively. 569 
In the present study, the T1DM group had significantly lower overall SSQ scores and 570 
consistently reported significantly more difficulties than the control group on the SSQ 571 
subscales. Different patterns of results across the subscales were observed in the two groups. 572 
Both groups reported having the least disability on items from the Qualities subscale, but 573 
whereas the control group had roughly equal mean scores on the Speech and Spatial 574 
subscales, the T1DM group reported the greatest disability on items from the Spatial 575 
subscale. This was evidenced by the significant interaction observed between group and SSQ 576 
subscale, which probably was driven by the T1DM group’s relatively low scores on the 577 
Spatial subscale. In keeping with the results of Rance et al. (2016), the present study provides 578 
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evidence that T1DM is associated with self-report of auditory disability in the absence of an 579 
elevation in audiometric threshold.  580 
Relations Between Experimental Measures and the Effects of DM-Related Factors 581 
Relations Between Electrophysiological and Behavioral Measures 582 
Only ABR wave I latency, in the T1DM group, was negatively correlated with the 583 
FDL. No other correlations were found between the amplitudes and latencies of waves I and 584 
V and the behavioral measures obtained in study two in the healthy control and T1DM 585 
groups considered independently. The present data also show no link between the 586 
synchronization strength and group delay latency of the FFR and the behavioral measures 587 
when the groups were considered independently (although there were, unsurprisingly, strong 588 
correlations across the whole cohort between these measures as they were all affected by 589 
DM).  590 
The finding that the FFR did not correlate with FDLs for either group considered 591 
independently is keeping with Clinard et al. (2010), who, using pure tone stimuli, did not 592 
observe a correlation between FFR measures and FDLs in normal hearing listeners. However, 593 
this is contrary to other observations (Marmel et al. 2013; Xu & Gong, 2014) of a negative 594 
correlation between FFR magnitude and FDL measures of temporal coding (higher FFR 595 
related to better performance).  596 
The absence of significant correlations in the present study means that one should be 597 
cautious about concluding that the neural deficits observed were in some way causally linked 598 
to the behavioral deficits. However, this remains a possibility, despite these negative findings.  599 
Relation Between Self-Report of Auditory Disability and Electrophysiological and 600 
Behavioral Measures 601 
There was a strong correlation between overall SSQ score and SNR in the separated 602 
condition, for the T1DM group. The pattern of these correlations points to some degree of 603 
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binaural deficits in DM participants, possibly due to their reduced sensitivity to TFS 604 
information, supporting the hypothesis that binaural deficits underlie the self-reported deficits 605 
in T1DM. However, the overall results are equivocal, taking into consideration the 606 
contradictory evidence reported above that no significant difference was found between the 607 
control and T1DM groups in SRM, while the difference in SNRs between the two groups was 608 
roughly equal in separated and co-located conditions.  609 
Effects of DM-Related Factors 610 
DM participants with the longest DM duration displayed the lowest FFR SNRs for 611 
responses to both the envelope and TFS. This suggests that the FFR is sensitive to auditory 612 
processing deficits which ensue from subtle vascular, metabolic and/or endocrine 613 
derangements, associated with T1DM, although DM duration did not correlate significantly 614 
with any of the other measures. Strong correlations between DM duration and hearing deficits 615 
in DM patients have been reported (Taylor & Irwin, 1978; Virtaniemi et al. 1994; Parving et 616 
al. 1990). However, others have not observed such effects in longer lasting DM (Dabrowski 617 
et al. 2011; Ottaviani et al. 2002).  618 
The present data provide no evidence that patients with diabetic neuropathy or 619 
retinopathy are more likely to present with neuropathic complications involving the AN and 620 
central auditory pathways: no correlation was found between the presence of neuropathy or 621 
retinopathy and greater hearing deficits. These findings are in keeping with Lisowska et al. 622 
(2001) and Tay et al. (1995), and in contrast to those of Virtaniemi et al. (1994), Bayazít et al. 623 
(2000) and Rance et al. (2014).  624 
The lack of correlation in our study between hearing deficits and the presence or 625 
retinopathy and neuropathy may in part be explained by: (1) a lack of power in the present 626 
study; (2) by the use of self-report to determine whether or not each DM participant had 627 
diagnosed clinical neuropathy or retinopathy, making the findings unreliable. Moreover, the 628 
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majority of our DM participants (especially those following up with general practitioners 629 
rather than specialized DM centers) reported that they had not undergone neurological exams 630 
for over a year. For this reason, a short questionnaire was used to take relevant DM-related 631 
history from all DM participants, while each participant with no confirmed clinical 632 
neuropathy diagnosis was also screened for the absence or presence of typical neuropathy 633 
symptoms such as numbness, shooting pain and burning pain. Thirteen of the 24 DM 634 
participants with no clinically diagnosed neuropathy confirmed the presence of one or more 635 
typical neuropathy symptoms. Thus, there is a possibility that some of those patients actually 636 
had the condition but had not been diagnosed. So far, only Rance et al. (2014) and colleagues 637 
appear to have performed all necessary measurements confirming the presence of diabetic 638 
neuropathy in six out of 10 subjects with T1DM in their study population. They found 639 
auditory dysfunction to be correlated with both visual acuity and degree of somatic peripheral 640 
neuropathy.  641 
Are the DM-Related Deficits due to Peripheral or Central Auditory Processing Deficits? 642 
Pathological and clinical studies of DM-related auditory dysfunction in both animals  643 
and humans have been inconclusive in determining the underlying causes or whether there is 644 
a pattern of pathological deterioration. Hence, the site of lesion in DM-related auditory 645 
dysfunction is still strongly contested. Various studies have reported different effects on 646 
anatomical structures and have proposed causes such as: interference of nutrient 647 
transportation due to a thickening in the vessels of the BM, oxidative stress—i.e., the 648 
excessive production of reactive oxygen species from electron leakage in the mitochondria 649 
caused by the hyperglycaemic state, resulting in neuronal cell death (Akinpelu et al. 2014b), 650 
atrophy of spiral ganglion neurons, demyelination of the AN, and the loss of outer hair cells 651 
or inner hair cells (Makishima & Tanaka, 1971; Fukushima et al. 2006; Kariya et al. 2010).  652 
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These pathological changes and metabolic disturbances can result in peripheral 653 
(cochlear), central auditory pathway, or combined peripheral and central deficits. The 654 
findings of previous research on auditory function in patients with T1DM are highly 655 
contradictory. For example, Ottaviani et al. (2002) report cochlear dysfunction, as measured 656 
by OAEs, in normal-hearing T1DM patients and Lisowska et al. (2001) report peripheral and 657 
central auditory dysfunctions, as measured by DPOAEs and ABRs, in normal-hearing T1DM 658 
patients, whereas normal-hearing T1DM patients in the Rance et al. (2014) study who 659 
showed evidence of central auditory pathway abnormality had DPOAEs present in each ear, 660 
indicating normal cochlear function, and absolute latencies and amplitudes for wave I of the 661 
click-evoked ABR equivalent to the age- and sex-matched controls.  662 
The present data are consistent with the findings of Rance et al. (2014) showing no 663 
evidence for cochlear neuropathy in the T1DM group. In the present study, absolute latencies 664 
and amplitudes for wave I of the click-evoked ABR were similar to those for the age-, sex- 665 
and PTA-matched healthy controls, whereas the rest of the results provide substantial 666 
evidence for DM-related central auditory deficits; these include reduced FFR responses, 667 
higher IPD and FDL thresholds, and worse speech-in-noise performance. In terms of 668 
identifying a site of lesion, the FFRsub results are most specific. Phase locking to TFS largely 669 
disappears moving upward through the auditory pathway, with the upper limit of phase locking 670 
reducing to 250 Hz or lower at the level of the primary auditory cortex (Wallace et al. 2002).  671 
Lower SNRs for the subtracted polarities (TFS) in the T1DM group suggest the presence of a 672 
lesion either in the rostral brainstem or earlier in the auditory pathway.  It should be noted 673 
that a limitation of the present study was that OAEs were not measured. It is possible that 674 
OAE measures would have revealed cochlear dysfunction not revealed by PTA. 675 
A possible explanation for greater DM-related effects being evident using central 676 
measures such as FFR, rather than peripheral measures such as PTA, OAEs and wave I of the 677 
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ABR, is that the auditory pathway can be thought of as comprising several processing stages, 678 
each of which may be affected by relatively subtle alterations, for example a certain 679 
percentage of neural loss. The initial effects of DM at each stage may be small, but the 680 
cumulative effects will increase with each additional stage reached. Thus, it may be 681 
speculated that if the neural response is reduced at each stage of the pathway, albeit by only a 682 
small percentage, then by the time the bottom-up input from the cochlea has passed several 683 
stages, the response may have decreased significantly. 684 
Limitations  685 
Although the present study corrected for multiple comparisons within each main 686 
outcome measure category, a more conservative approach would be correct across all of the 687 
outcome measures. When this was done across all 29 group comparisons (α = 0.0017), most 688 
of the significant comparisons remained significant, although a few comparisons (FFRsub 689 
upper side band SNR, FDL, SSQ speech subscale, and SSQ qualities subscale) did not 690 
survive correction with this conservative criterion. Hence a future, more focussed, validation 691 
study would be useful to confirm that these measures are associated with T1DM. 692 
Moreover, although T1DM is not typically associated with reduced intelligence, 693 
subtle neurocognitive impairments were reported in children (Schoenle et al. 2002; Ryan, 694 
1999; Ryan et al. 1990; Rovet & Alvarez, 1997) and adults (Bale, 1973; Ryan & Williams, 695 
1993; Skenazy and Bigler, 1984) with T1DM. The frequent transient alterations of blood 696 
glucose levels which DM patients experience have been found to affect attentional abilities in 697 
children (Ryan et al. 1990; Davis et al. 1996) and adults with DM (Holmes et al. 1983; 698 
Widom & Simonson, 1990), as well as in nondiabetic healthy participants (McCrimmon et al. 699 
1996; Stevens et al. 1989). Poorer attention has been reported in adults with longstanding DM 700 
(Bale, 1973; Ryan & Williams, 1993) and has been related to chronic hyperglycaemia, 701 
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duration of DM (Ryan et al. 1993), and recurrent severe hypoglycaemia (Skenazy & Bigler, 702 
1984; Langan et al. 1991; McCrimmon et al. 1996). A meta-analysis by Brands et al. (2005), 703 
provided evidence of significantly lowered cognitive performance in the T1DM patients 704 
compared to nondiabetic healthy controls. The pattern of their findings does not support an 705 
overall impairment of cognitive abilities in T1DM patients, but rather mild to moderate 706 
deficits resulting in a slowing of mental processing and diminished mental flexibility. The 707 
authors report that lowered cognitive performance seemed to be associated with the presence 708 
of microvascular complications but not with hypoglycaemic episodes or poor metabolic 709 
control.  710 
The majority of the T1DM group in the current study, especially those with longer DM 711 
duration, were diagnosed when they were children. Children with T1DM are at greater risk of 712 
frequent high and low blood glucose excursions, recurrent episodes of acute hypoglycaemia 713 
and hypoglycaemic seizures. These factors have been related to subtle impairment of 714 
cognitive functions (Schoenle et al. 2002; Ryan, 1999; Golden et al. 1989; Rovet & Ehrlich, 715 
1999). Hence, it is possible that multiple aspects of cognitive functioning may have been 716 
disrupted in the present study’s young, normal-hearing T1DM group, which may have 717 
affected performance on the behavioural tasks in the study. The current study did not assess 718 
whether there had been a history of severe episodes of hypoglycaemia and/or hypoglycaemic 719 
seizures among the DM patients. Moreover, participation in the study was quite time 720 
consuming and may have been associated with fatigue. Although this was minimized through 721 
the taking of regular breaks with the provision of refreshments suitable for DM patients, no 722 
measurement of blood glucose was taken to confirm the absence of hypoglycaemia. Future 723 
work is strongly encouraged in order to understand further the mechanisms that underlie the 724 
auditory deficits in T1DM patients. Such research should use diagnosis confirmed through 725 
neurological assessment, in order to explore whether the presence of neuropathy or of 726 
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retinopathy are risk factors for AN and central auditory pathway involvement in patients with 727 
T1DM. Cognitive studies which carefully review T1DM patients’ medical history are also 728 
required to investigate the potential impact of cognitive problems and of individual 729 
differences in cognitive functioning on understanding speech-in-noise in patients with 730 
T1DM.  731 
CONCLUSIONS 732 
The main conclusions drawn from this study can be summarized as follows:  733 
1. Despite clinically normal hearing detection levels as measured by PTA, clear 734 
neural deficits are seen in T1DM patients, evidenced by reduced synchrony to the 735 
temporal envelope and TFS in the FFR, and by elevated IPD thresholds and FDLs.  736 
2. T1DM is associated with deficits in real-world hearing ability, including speech-737 
in-noise perception and self-reported ability. However, nonauditory deficits 738 
associated with T1DM, including cognitive deficits, may contribute to variability 739 
in real-world performance.  740 
3. The results suggest strongly that PTA is not fit for purpose as a measure of the 741 
underlying hearing dysfunction in T1DM patients. The FFR may provide a 742 
sensitive early indicator of neural damage in T1DM, before any abnormalities can 743 
be identified using standard clinical tests.744 
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Figure 1: Mean air conduction audiometric thresholds of the test ears of the two groups. 
Error bars show SEs. 
Figure 2: Grand average auditory brainstem response (ABR) waveforms plotted for the 
control and type 1 diabetes mellitus (T1DM) groups (n=30 in each group). The solid line 
shows the mean response across individuals and the shaded area shows 95% confidence 
intervals calculated for each time point. 
Figure 3:  Peak-to-trough amplitudes (upper panel) and latencies (lower panel) for auditory 
brainstem response (ABR) waves I, III, and V. The rectangle shows the interquartile range 
(IQR). For this and subsequent plots, the bold lines inside rectangles show the median, and 
whiskers show the maximum and minimum values excluding outliers. Open circles show 
outliers defined as 1.5 x IQR or more above the third quartile or 1.5 x IQR or more below the 
first quartile. 
Figure 4: Average waveforms and spectra of the frequency-following response (FFR) for the 
stimulus with frequency components 475, 590, and 705 Hz for the control and type 1 diabetes 
mellitus (T1DM) groups. A, the addition waveform reflecting phase locking to the temporal 
envelope. B, the subtraction waveform reflecting phase locking to the temporal fine structure. 
C, the spectrum of the addition waveform. D, the spectrum of the subtraction waveform. 
Figure 5: Upper panel: signal-to-noise ratios (SNR) for the addition waveform (FFRadd), 
the lower side band subtraction waveform (FFRsub lower side band), the upper side band 
subtraction waveform (FFRsub upper side band), and the mean subtraction waveform (Mean 
FFRsub). Lower panel: Group delays for FFRadd (N= 17), FFRsub lower side band (N= 22), 
FFRsub upper side band (N= 17) and Mean FFRsub (N= 29). 
Figure 6: A, interaural phase difference thresholds (IPD). B, frequency difference limens 
(FDL). 
Figure 7: signal-to-noise ratios (SNR) for 50% correct for the separated and co-located 
speech-in-noise conditions. 
Figure 8: the Speech, Spatial and Qualities (SSQ) subscale scores and the overall SSQ 
scores. 
Figure 9: Type 1 diabetes mellitus (T1DM) duration plotted as a function of A, the addition 
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LIST OF SUPPLEMENTAL DIGITAL CONTENT 
Supplemental Digital Content 1. Table that shows the details of the 30 type 1 diabetes 
mellitus (T1DM) participants. 
Supplemental Digital Content 2. Table that shows the details of the 30 matched pairs. 
Supplemental Digital Content 3. Table that shows the statistics for all variables used in the 
analyses on the auditory brainstem response (ABR) data. 
Supplemental Digital Content 4. Table that shows the statistics for all variables used in the 
analyses on the frequency-following response (FFR) group delay data. 
Supplemental Digital Content 5. Table that shows the correlation between 
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Table 1: Statistics for frequency-following response (FFR) signal-to-noise ratio (SNR) Group 
Comparisons2.  
 





(dB)    
SD  t p 
 
FFRadd SNR  
Control 30 12.11 3.68 
-4.71 <0.001** 
T1DM 30 7.93 4.27 
 
FFRsub lower side band 
SNR  
Control 30 15.28 2.94 
-3.86 <0.001** 
T1DM 30 11.78 4.45 
 
FFRsub upper side band 
SNR 
Control 30 12.58 4.78 
-3.39 0.002** 
T1DM 30 8.81 5.10 
 
Mean FFRsub SNR  
Control 30 13.89 3.45 
-4.77 <0.001** 






                                                 
2 Asterisks denote a significant difference between the two groups: **p < Bonferroni corrected α 
(0.0063). 
Frequency-following response measures (FFR Measure): signal-to-noise ratios for the addition 
waveform (FFRadd SNR), signal-to-noise ratios for the subtraction waveform lower side band 
(FFRsub lower side band SNR), signal-to-noise ratios for the subtraction waveform upper side band 
(FFRsub upper side band SNR), and signal-to-noise ratios for the mean subtraction waveform (Mean 
FFRsub SNR). Comparison between the two groups [control or type 1 diabetes mellitus (T1DM)]: 
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Table 2: Statistics for the Behavioral Group Comparisons3.  
 
Behavioral Measure Experimental 
Group 
Mean SD t p 
IPD threshold 
 
Control 1.51 0.29 
3.97 <0.001** 
T1DM 1.72 0.29 
FDL 
 
Control -0 .42 0.29 
 3.43 0.002** 
T1DM -0.18 0.32 
SNR separated   Control -9.97 1.84 
 4.05 <0.001** 
T1DM -8.38 2.39 
SNR co-located  Control -6.12 1.61 
5.19 <0.001** 
T1DM -4.46 1.66 
SRM Control 3.84 1.26 
0.23 0.82 






                                                 
3 Asterisks denote a significant difference between the two groups:  **p < Bonferroni corrected α 
(0.01). 
Behavioral Measures: log-transformed interaural phase difference threshold (IPD threshold) [in log10 
Degrees], log-transformed frequency difference limen (FDL) [in log10 Percentage], signal-to-noise 
ratio for 50% correct in separated speech condition (SNR separated) [in dB], signal-to-noise ratio for 
50% correct in co-located speech condition (SNR co-located) [in dB] and spatial release from 
masking (SRM) [in dB]. Comparison between the two groups [control or type 1 diabetes mellitus 
(T1DM)]: standard deviation (SD), and t value from the paired samples t test (t). 
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Table 3: Statistics for the Speech, Spatial and Qualities (SSQ) subscale scores and the overall SSQ 
scores Group Comparisons4.  
 
SSQ Score Experimental 
Group 
Mean Score SD   t p 
                                    
Speech subscale 
Control 8.79 0.79 
    -2.10  0.006** 
T1DM 8.04 0.69 
  
Spatial subscale 
Control 8.82 0.84 
   -5.39  <0.001** 
T1DM 7.64 0.72 
  
Qualities subscale 
Control 9.42 0.51 
   -3.34  0.002** 
T1DM 8.45 0.93 
 
Overall  
Control 8.94 0.65 
   -4.17  <0.001** 








                                                 
4 Asterisks denote a significant difference between the two groups:  **p < Bonferroni correction α (< 
0.013). Comparison between the two groups [control or type 1 diabetes mellitus (T1DM)]: standard 
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Presence of Some Neuropathy 
Symptoms Confirmed by 
Participant in the Absence of 
Clinically Diagnosed 
Neuropathy 
1 F 11 No Yes NA 
2 M 21 No Yes NA 
3 F 25 No No Numbness and burning pain 
4 M 9 Yes No Shooting pain and burning pain 
5 F 18 No No None 
6 F 20 Yes No Shooting pain and burning pain 
7 M 12 Yes No None 
8 M 15 No No None 
9 F 18 Yes No Numbness and burning pain 
10 F 4 No No None 
11 F 10 No Yes NA 
12 F 19 Yes No Numbness 
13 F 8 No No None 
14 F 25 Yes No Burning pain 
15 M 20 Yes No None 
16 F 15 No Yes NA 
17 F 14 No No None 
18 F 9 No No Burning pain 
19 F 24 No No Numbness and shooting pain 
20 M 28 No No Numbness and shooting pain 
21 M 12 Yes No None 
22 M 6 No No None 
23 F 10 Yes No Numbness and shooting pain 
24 F 15 No Yes NA 
25 F 8 No No None 
26 F 26 No No Burning pain 
27 F 24 Yes No Numbness and burning pain 
28 F 26 No No Numbness 
29 F 16 No No None 
30 M 18 No Yes NA 
                                                 
5 Listed by duration of type 1 diabetes mellitus (T1DM Duration) in years, and whether or not 
each had diagnosed clinical neuropathy or retinopathy (self-reported). For each participant 
with no diagnosed clinical neuropathy, the table also provides the absence or presence, 
confirmed by the participant, of typical neuropathy symptoms: numbness, shooting pain, 
burning pain, or none. Not applicable (NA) for participants with diagnosed clinical 
neuropathy. 
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6 Listed by sex, age, experimental group [control or type 1 diabetes mellitus (T1DM)], 
audiometric threshold of the test ear at 0.5, 1, 2, and 4 kHz, and average audiometric 
threshold (0.5- 4 kHz). 
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         Audiometric Threshold of the Test Ear  
Pair 
No. 




   0.5 kHz  
 
 1 kHz  
 
 2 kHz  
 
 4 kHz  
 
  Average  
0.5-4 kHz  
1 F 32 Control 0 15 -5 5 3.75 
T1DM 5 5 0 5 3.75 
2 M 34 Control 0 5 10 10 6.25 
T1DM 0 5 5 20 7.5 
3 F 27 Control 10 10 5 10 8.75 
T1DM 5 10 10 5 7.5 
4 M 31 Control 0 10 5 0 3.75 
T1DM 5 5 10 5 6.25 
5 F 24 Control 5 0 5 5 3.75 
T1DM 0 0 0 5 1.25 
6 F 22 Control 0 5 5 0 2.5 
T1DM 0 5 5 10 5 
7 M 24 Control 5 5 5 0 3.75 
T1DM 0 0 5 5 2.5 
8 M 30 Control 10 15 10 5 10 
T1DM 5 5 5 5 5 
9 F 21 Control 5 0 10 0 3.75 
T1DM 5 5 0 5 3.75 
10 F 22 Control 5 5 0 0 2.5 
T1DM 5 0 0 0 1.25 
11 F 28 Control 15 10 5 0 7.5 
T1DM 10 5 0 5 5 
12 F 25 Control 0 -5 0 0 -1.25 
T1DM 10 5 0 0 3.75 
13 F 21 Control 10 5 0 10 6.25 
T1DM 5 -5 0 10 2.5 
14 F 29 Control 0 -5 0 0 -1.25 
T1DM 5 0 5 0 2.5 
15 F 30 Control 0 5 5 0 2.5 
T1DM 10 5 5 10 7.5 
16 F 22 Control 10 5 15 5 8.75 
T1DM 5 5 0 5 3.75 
17 F 28 Control 5 5 0 0 2.5 
T1DM 0 10 10 5 6.25 
18 F 20 Control 5 5 5 10 6.25 
T1DM 0 5 0 5 2.5 
19 F 28 Control 15 0 0 0 3.75 
T1DM 10 5 5 5 6.25 
20 M 30 Control 0 5 0 5 2.5 
T1DM 0 0 0 10 2.5 
21 M 19 Control 5 0 -5 -5 -1.25 
T1DM 5 5 0 0 2.5 
22 M 33 Control 10 10 10 0 7.5 
T1DM 20 15 10 5 12.5 
23 F 25 Control 10 5 0 10 6.25 
T1DM 15 10 10 10 11.25 
24 F 18 Control 0 0 0 10 2.5 
T1DM 10 5 0 5 5 
25 F 21 Control 5 5 0 -5 1.25 
T1DM 10 5 5 0 5 
26 F 28 Control 10 0 5 5 5 
T1DM 15 10 5 10 10 
27 F 26 Control 10 10 15 0 8.75 
T1DM 20 20 5 10 13.75 
28 F 32 Control 0 5 0 0 1.25 
T1DM 10 5 0 -5 2.5 
29 F 24 Control 10 10 5 0 6.25 
T1DM 10 5 5 0 5 
30 M 22 Control 0 5 5 10 5 
T1DM 5 5 10 15 8.75 
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Supplemental Digital Content 3:  Statistics for all variables used in the analyses on the 
auditory brainstem response (ABR) data7. 
 
ABR measure Experimental 
group 
Mean SD   t/z p 
 
Wave I amplitude  
Control 409.26 389.53 
-1.79 (t) 0.08 
T1DM 318.62 231.82 
 
Wave III amplitude  
Control 459.17 334.27 
-1.29 (t) 0.21 
T1DM 364.92 260.46 
 
Wave V amplitude  
Control 640.67 441.34 
-0.75 (z) 0.45 
T1DM 575.83 349.42 
 
Wave I-III amplitude ratio  
Control 1.24 1.28 
0.63 (z) 0.53 
T1DM 1.41 2.65 
 
Wave III-V amplitude 
ratio  
Control 0.73 0.59 
-0.18 (z) 0.86 
T1DM 0.79 0.70 
 
Wave I-V amplitude ratio  
Control 0.67 0.60 
0.59 (z) 0.56 
T1DM 0.70 0.43 
 
Wave I latency  
Control 1.69 0.09 
1.24 (z) 0.22 
T1DM 1.71 0.20 
 
Wave III latency  
Control 3.79 0.22 
0.39 (t) 0.70 
T1DM 3.81 0.23 
 
Wave V latency  
Control 5.45 0.34 
1.04 (t) 0.31 
T1DM 5.53 0.31 
 
Wave I-III interval  
Control 2.10 0.22 
0.06 (t) 0.95 
T1DM 2.10 0.19 
 
Wave III-V interval  
Control 1.66 0.33 
0.76 (t) 0.45 
T1DM 1.72 0.35 
 
Wave I-V interval  
Control 3.76 0.32 
0.78 (t) 0.44 




                                                 
7 Auditory brainstem response measures (ABR measure): auditory brainstem response peak-
to-trough amplitudes (amplitude) [in nV], auditory brainstem response peak-to-trough amplitude 
ratios (amplitude ratio), auditory brainstem response absolute latencies (latency) [in ms], and auditory 
brainstem response inter-peak interval (interval) [in ms]. Comparison between the two groups [control 
or type 1 diabetes mellitus (T1DM)]: standard deviation (SD), and t value from the paired samples t 
test (t) or z value from the Wilcoxon signed-ranks test (z). 
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Supplemental Digital Content 4: Statistics for frequency-following response (FFR) group 
delay data used in the analyses8. 
 




Mean    SD t p 
 
FFRadd group delay  
Control 17 5.92 3.34 
0.66 0.51 
T1DM 17 7.03 3.96 
 
FFRsub lower side band 
group delay  
Control 22 7.30 1.75 
0.97 0.35 
T1DM 22 7.90 1.94 
 
FFRsub upper side band 
group delay  
Control 17 7.76 3.96 
0.62 0.54 
T1DM 17 8.73 5.95 
 
Mean FFRsub group 
delay  
 
Control 29 7.46 3.45 
1.64 0.11 







                                                 
8 Group delay for the addition waveform (FFRadd group delay) [in ms], group delay for the 
subtraction waveform lower side band (FFRsub lower side band group delay) [in ms], group delay for 
the subtraction waveform upper side band (FFRsub upper side band group delay) [in ms], and group 
delay for the mean subtraction waveform (Mean FFRsub group delay) [in ms]. Comparison between 
the two groups [control or type 1 diabetes mellitus (T1DM)]: number of participants (No. participant), 
standard deviation (SD), and t value from the paired samples t test (t). 
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9 Asterisks denote a significant difference between the two groups: *p < 0.05.  
Correlation coefficients (Pearson’s (r) and Spearman’s (rs)) and the probability values (p) for the 
correlations between electrophysiological amplitude and latency measures and behavioural measures, 
for the control and type 1 diabetes mellitus (T1DM) groups. Electrophysiological amplitude measures: 
auditory brainstem response peak-to-trough amplitudes of wave I (Wave I amplitude) [in nV], 
auditory brainstem response peak-to-trough amplitudes of wave V (Wave V amplitude) [in nV], 
signal-to-noise ratios for the frequency-following response addition waveform (FFRadd SNR) [in 
dB], signal-to-noise ratios for the frequency-following response mean subtraction waveform (Mean 
FFRsub SNR) [in dB]. Electrophysiological latency measures: auditory brainstem response absolute 
latency of wave I (Wave I amplitude) [in ms], auditory brainstem response absolute latency of wave V 
(Wave V amplitude) [in ms], group delay for the frequency-following response addition waveform 
(FFRadd group delay) [in ms], and group delay for the frequency-following response mean 
subtraction waveform (Mean FFRsub group delay) [in ms]. Behavioural measures: log- transformed 
interaural phase difference threshold (IPD threshold) [in log10 Degrees], log- transformed frequency 
difference limen (FDL) [in log10 percentage], signal-to-noise ratio for 50% correct in the separated 
speech condition (SNR separated) [in dB], and signal-to-noise ratio for 50% correct in the co-located 
speech condition (SNR co-located) [in dB]. 
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                 Measures Control Group TIDM Group 
Electrophysiological               
Measure 








Wave I amplitude IPD threshold 0.25 (rs)   0.19 0.34 (r)   0.07 
Wave I amplitude FDL  0.11 (rs)   0.55 0.17 (r)   0.37 
Wave I amplitude SNR separated  0.20 (rs)   0.29 -0.66 (r)   0.73 
Wave I amplitude 
SNR co-located  
-0.20 (rs)   0.92 0.02 (r)   0.90 
Wave V amplitude IPD threshold 0.25 (rs)   0.18 -0.17 (r)   0.38 
 
Wave V amplitude FDL  
0.19 (rs)   0.31 0.01 (r)   0.97 
 
Wave V amplitude SNR separated 
-0.20 (rs)   0.29 -0.66 (r)   0.73 
 
Wave V amplitude SNR co-located 
-0.20 (rs)   0.92 -0.23 (r)   0.90 
FFRadd SNR IPD threshold -0.23 (rs)  0.22 -0.39 (r)   0.03* 
FFRadd SNR FDL  -0.19 (rs)  0.32 -0.04 (r)   0.83 
FFRadd SNR SNR separated  -0.06 (rs)   0.75  0.10 (r)   0.60 
FFRadd SNR 
SNR co-located 
 -0.17 (rs)   0.38 -0.04 (r)   0.82 
Mean FFRsub SNR IPD threshold 0.18 (r)   0.35 -0.20 (r)   0.29 
 
Mean FFRsub SNR FDL  
-0.09 (r)   0.65 -0.02 (r)   0.90 
 
Mean FFRsub SNR SNR separated 
0.01 (r)   0.97 0.14 (r)   0.45 
 
Mean FFRsub SNR SNR co-located 
-0.08 (r)   0.67 0.02 (r)   0.90 
Wave I latency IPD threshold -0.20 (r)   0.29  -0.41 (rs)   0.02* 
Wave I latency FDL  0.01 (r)   0.98 0.58 (rs)   0.001** 
Wave I latency SNR separated  -0.04 (r)   0.85 0.12 (rs)   0.54 
Wave I latency 
SNR co-located  
-0.10 (r)   0.30 0.11 (rs)   0.56 
Wave V latency IPD threshold -0.18 (r)   0.35 0.14 (r)   0.47 
 
Wave V latency FDL  
-0.20 (r)   0.30 -0.04 (r)   0.83 
 
Wave V latency SNR separated 
-0.22 (r)   0.24 -0.04 (r)   0.82 
 
Wave V latency SNR co-located 
-0.33 (r)   0.08 -0.09 (r)   0.66 
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FFRadd group delay IPD threshold 
-0.33 (rs)  
(n=27)  
0.09 
0.07 (rs)  
(n=18) 
0.80 
FFRadd group delay FDL  
-0.32 (rs)  
(n=27)  
0.11 
0.04 (rs)  
(n=18) 
0.89 
FFRadd group delay SNR separated 
-0.16 (rs)  
(n=27) 
0.43 
-0.14 (rs)  
(n=18) 
0.58 
FFRadd group delay 
 
SNR co-located 
0.13 (rs)    
(n=27)  
0.51 




Mean FFRsub group 
delay 
IPD threshold 
-0.22 (rs)  
(n=30) 
0.25 




Mean FFRsub group 
delay 
FDL  -0.14 (rs) 0.46 0.20 (rs) 0.30 
 
Mean FFRsub group 
delay 
 
 SNR separated 0.26 (rs) 0.10 0.42 (rs) 0.02* 
 
Mean FFRsub group 
delay 
SNR co-located 0.00 (rs) 0.50 0.28 (rs) 0.15 
 
 
 
 
 
 
 
 
